BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Deals

  Perrigo Company Scoops Up Basket Of Value-Brand OTC Drugs For $51 Million Cash

  February 28, 2014

   · 

  3 min read
• Bayer AG Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs

  February 28, 2014

   · 

  1 min read
• Genetown

  Verastem, Inc. Supports Worldwide Rare Disease Day On February 28, 2014

  February 28, 2014

   · 

  1 min read
• TRANSGENE Launches A Rights Issue Of €45.5 Million Euros At A Price Of 10 Euros Per Share

  February 28, 2014

   · 

  1 min read
• Pharm Country

  Weill Cornell Medical College Scientists Uncover Trigger For Most Common Form Of Intellectual Disability And Autism

  February 28, 2014

   · 

  7 min read
• FDA

  Vectura Group plc: South Korean Regulatory Authority Confirm Approval Of AirFluSal® Forspiro®

  February 28, 2014

   · 

  3 min read
• Genetown

  Genzyme Corporation Recognizes International Rare Disease Day With Global Awareness Programs And Launch Of Fourth Annual Patient Advocacy Leadership (PAL) Awards

  February 28, 2014

   · 

  1 min read
• Business

  Alnylam Pharmaceuticals Announces Closing of Previously Announced Alliance With Genzyme Corporation For Discovery, Development, And Commercialization Of RNAi Therapeutics As Genetic Medicines

  February 28, 2014

   · 

  1 min read
• Business

  MorphoSys AG Reports Results for Fiscal Year 2013

  February 28, 2014

   · 

  1 min read
• Business

  Portola Pharmaceuticals, Inc. Reports Fourth Quarter And Year-End 2013 Financial Results And Provides Corporate Update

  February 28, 2014

   · 

  1 min read